Healthcare Services

Dupuytren’s disease market growth outlook through 2030

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Dupuytren’s Disease Market During The Forecast Period?

The market size for dupuytren’s disease has experienced significant expansion in recent times. It is anticipated to expand from $4.51 billion in 2025 to $4.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.7%. This historical growth can be attributed to several factors including an increasing aging population, the prevalence of orthopedic disorders, the widespread availability of surgical treatments, the standardization of clinical diagnosis, and the adoption of hand therapy.

The market for dupuytren’s disease is projected to experience robust expansion over the coming years. This market is forecast to reach $5.94 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.7%. Key factors contributing to this anticipated growth include advancements in biologic therapies, innovations in minimally invasive procedures, the broadening of outpatient care options, a heightened emphasis on patient quality of life, and the expansion of rehabilitation services. Noteworthy trends expected during this period involve the increasing uptake of minimally invasive treatments, a greater reliance on enzyme injection therapies, a shift towards outpatient surgical procedures, enhanced early diagnosis and physical examinations, and a concentrated effort on post-treatment rehabilitation.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/dupuytrens-disease-global-market-report

Which Strong Drivers Are Impacting The Dupuytren’s Disease Market Growth?

The future expansion of the Dupuytren’s disease market is anticipated due to the increasing adoption of minimally invasive treatments. These treatments involve medical interventions with slight cuts or minimal tissue damage, leading to less discomfort, quicker healing, and reduced scar formation. Patients and medical professionals increasingly favor minimally invasive approaches over conventional open surgeries because they offer faster recuperation, less pain, and lower risks of complications. In alignment with this trend, the Dupuytren’s disease market provides minimally invasive choices that enhance hand mobility, alleviate finger stiffness, and improve post-treatment results for those affected. As an illustration, data from June 2024, provided by the American Society of Plastic Surgeons, a US-based non-profit body, revealed a 7% rise in minimally invasive procedures in 2023, which surpassed the growth of surgical procedures by 2%. Hand operations, including those for carpal tunnel, arthritis, and trigger finger, reached 207,887 procedures, marking a 2% increase compared to 2022. Consequently, the expansion of minimally invasive treatments is propelling the development of the Dupuytren’s disease market.

How Are Segments Identified Within The Dupuytren’s Disease Market Segment Framework?

The dupuytren’s disease market covered in this report is segmented –

1) By Disease Type: Type I, Type II, Type III

2) By Treatment: Surgery, Radiation Therapy, Needle Aponeurotomy, Steroid Shot, Enzyme Injection, Occupational Therapy, Other Treatments

3) By Route of Administration: Oral, Parenteral, Other Routes Of Administration

4) By Diagnosis: Physical Examination, X-Ray, Other Diagnosis

5) By End-User: Hospitals, Clinics, Academic And Research Institute, Other End-Users

Subsegments:

1) By Type I: Classical Dupuytren’s Disease, Familial Dupuytren’s Disease

2) By Type II: Palmar Fasciitis, Ledderhose Disease

3) By Type III: Garrod’s Pads, Peyronie’s Disease

Which Trends Are Contributing To Changes In The Dupuytren’s Disease Market?

Key players in the Dupuytren’s disease market are prioritizing clinical trials to create new, primary, disease-altering treatments designed to halt or revert the advancement of fibrosis. These trials are organized research studies evaluating the safety, effectiveness, and potential adverse reactions of novel drugs, treatments, or medical interventions in human subjects prior to obtaining regulatory approval and broad clinical application. An example is Ventoux Biosciences, a US-based biopharmaceutical firm focused on non-surgical Dupuytren’s disease treatments, which disclosed favorable preclinical findings in April 2023 for VEN-201, its primary fibrosis therapy. This drug, a repurposed commercial product, showed effectiveness in lessening skin fibrosis in mouse models of Dupuytren’s contracture. These encouraging outcomes led the company to begin fundraising to progress VEN-201 into clinical trials as a potential therapy capable of modifying the disease.

Who Are The Companies Competing Within The Dupuytren’s Disease Market?

Major companies operating in the dupuytren’s disease market are Pfizer Inc., Aetna Inc., Mayo clinic, Penn Medicine, Mercy Health, Endo Inc., Resilience Orthopedics, Raleigh Orthopaedic, Hoag Orthopedic Institute, OSS Health, Connext Inc., University of Utah Health, Ventoux Biosciences Inc., Auxilium Pharmaceuticals, 180 Life Sciences Corp., Brigid Freyne MD, Nantong Jinghua Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Actiza Pharmaceutical Private Limited, Spear Pharmaceuticals

Get The Full Dupuytren’s Disease Market Report:

https://www.thebusinessresearchcompany.com/report/dupuytrens-disease-global-market-report

Which Region Accounts For The Largest Portion Of The Dupuytren’s Disease Market?

North America was the largest region in the dupuytren’s disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dupuytren’s disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Dupuytren’s Disease Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/dupuytrens-disease-global-market-report

Browse Through More Reports Similar to the Global Dupuytren’s Disease Market 2026, By The Business Research Company

Peripheral Arterial Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Rare Diseases Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Rare Neurological Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-neurological-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795